Smoldering Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Smoldering Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating selinexor for intermediate- and high-risk smoldering multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma [NA]
A clinical trial update indicates a BCMA/CD3 bispecific antibody is being studied for high-risk smoldering multiple myeloma, with the trial …
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Screening to Improve Survival in AL Amyloidosis
The clinical trial update reports completion of a screening-based study aimed at improving survival in light-chain (AL) amyloidosis. The stu…
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma [Phase 2]
A Phase 2 trial is evaluating Ciltacabtagene Autoleucel for high-risk smoldering multiple myeloma and is currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma [Phase 2]
Phase 2 clinical trial update evaluating Elranatamab in high-risk smoldering multiple myeloma. The study is currently recruiting and is spon…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating curcumin and piperine in patients under surveillance for monoclonal gammopathy, smoldering multiple myelom…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study [Phase 1]
Phase 1 pilot study evaluating ixazomib with dexamethasone in patients with high-risk smoldering myeloma and multiple myeloma; the trial has…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant [Phase 2]
Phase 2 clinical trial update investigating aggressive curative approach with novel therapies and transplant for smoldering multiple myeloma…
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: A Phase II Trial If Nivolumab, Lenalidomide and Dexamethasone in High Risk Smoldering Myeloma [Phase 2]
Phase II trial of nivolumab, lenalidomide, and dexamethasone in high-risk smoldering multiple myeloma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma [Phase 2]
Phase II trial (E-PRISM) evaluating elotuzumab, lenalidomide, and dexamethasone in high-risk smoldering multiple myeloma has completed with …
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: Denosumab for Smoldering Multiple Myeloma [Phase 2]
Phase 2 clinical trial of denosumab in smoldering multiple myeloma has completed and results were posted in February 2023.
-
CLINICAL_TRIALS trial_result · 2022-09-13Clinical Trial Update: Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma [Phase 2]
Phase 2 trial evaluating Carfilzomib, Lenalidomide, and Dexamethasone in Smoldering Multiple Myeloma has completed and results have been pos…
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma [Phase 2]
Phase 2 trial update evaluating carfilzomib in treatment patients under 65 with high-risk smoldering multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma [Phase 3]
A Phase 3 trial compared lenalidomide to observation in asymptomatic high-risk smoldering multiple myeloma; results were posted on May 18, 2…
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma [Phase 3]
Phase 3 trial comparing lenalidomide versus observation in asymptomatic high-risk smoldering multiple myeloma; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-01Clinical Trial Update: Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating melphalan and radiation therapy followed by lenalidomide in patients undergoing autologous stem cell transplant f…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Study of BHQ880 in Patients With High Risk Smoldering Multiple Myeloma [Phase 2]
Phase 2 trial evaluating BHQ880 in patients with high-risk smoldering multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Study on the Effect of Ibrutinib on High Risk Smoldering Multiple Myeloma Patients [Phase 2]
Phase 2 trial investigating ibrutinib in high risk smoldering multiple myeloma was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma [EARLY_Phase 1]
An early-phase study evaluating pembrolizumab in intermediate- to high-risk smoldering multiple myeloma. The trial is active but not recruit…
-
CLINICAL_TRIALS trial_result · 2019-08-16Clinical Trial Update: A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM) [Phase 2]
Phase 2 clinical trial investigating patients with smoldering and active multiple myeloma is currently enrolling by invitation.
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma [NA]
ClinicalTrials.gov entry noting the completed study evaluating genomic and psychosocial effects of the 3RP in patients with Monoclonal Gammo…
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma [Phase 1]
OncoPep, Inc. reports the completion of a Phase 1/2a cancer vaccine study for Smoldering Multiple Myeloma.
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma [Phase 2]
Phase 2 study of TBL 12 sea cucumber extract in patients with untreated asymptomatic myeloma; the trial was terminated and results were post…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer [Phase 1]
A Phase I clinical trial is evaluating an oncofetal antigen multi-peptide immunotherapy in hematologic cancers, including acute myeloid leuk…
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma [Phase 2]
Phase 2 biomarker study of elotuzumab in high-risk smoldering multiple myeloma has completed with results posted in 2016.